Compared to breast cancer metastasis epidemiology, hormone-receptor positive MCF-7 cells preferentially localize in bone, HER-2 positive SKBR3 cells to liver and lung, which aligns with epidemiological results. This evidence concerns the gene ERBB2 and breast carcinoma.